450 related articles for article (PubMed ID: 33073044)
1. Pathogenesis and pathways: nonalcoholic fatty liver disease & alcoholic liver disease.
Robinson KE; Shah VH
Transl Gastroenterol Hepatol; 2020; 5():49. PubMed ID: 33073044
[TBL] [Abstract][Full Text] [Related]
2. Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage.
Neuman MG; French SW; Zakhari S; Malnick S; Seitz HK; Cohen LB; Salaspuro M; Voinea-Griffin A; Barasch A; Kirpich IA; Thomes PG; Schrum LW; Donohue TM; Kharbanda KK; Cruz M; Opris M
Exp Mol Pathol; 2017 Feb; 102(1):162-180. PubMed ID: 28077318
[TBL] [Abstract][Full Text] [Related]
3. Fatty Liver Disease-Alcoholic and Non-Alcoholic: Similar but Different.
Malnick SDH; Alin P; Somin M; Neuman MG
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555867
[TBL] [Abstract][Full Text] [Related]
4. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology.
Loria P; Marchesini G; Nascimbeni F; Ballestri S; Maurantonio M; Carubbi F; Ratziu V; Lonardo A
Atherosclerosis; 2014 Jan; 232(1):99-109. PubMed ID: 24401223
[TBL] [Abstract][Full Text] [Related]
6. Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V; Handa P; Kowdley KV
Clin Liver Dis; 2018 Feb; 22(1):23-37. PubMed ID: 29128059
[TBL] [Abstract][Full Text] [Related]
7. NAFLD: Is There Anything New under the Sun?
Lonardo A; Targher G
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28895919
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic fatty liver disease.
Grant LM; Lisker-Melman M
Ann Hepatol; 2004; 3(3):93-9. PubMed ID: 15505593
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic disease modifiers: non-alcoholic fatty liver disease (NAFLD) and alcoholic liver disease (ALD).
Choudhary NS; Duseja A
Transl Gastroenterol Hepatol; 2021; 6():2. PubMed ID: 33409397
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
Streba LA; Vere CC; Rogoveanu I; Streba CT
World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
[TBL] [Abstract][Full Text] [Related]
11. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
12. Role of fatty liver, dietary fatty acid supplements, and obesity in the progression of alcoholic liver disease: introduction and summary of the symposium.
Purohit V; Russo D; Coates PM
Alcohol; 2004 Aug; 34(1):3-8. PubMed ID: 15670659
[TBL] [Abstract][Full Text] [Related]
13. Key Signaling in Alcohol-Associated Liver Disease: The Role of Bile Acids.
Way GW; Jackson KG; Muscu SR; Zhou H
Cells; 2022 Apr; 11(8):. PubMed ID: 35456053
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?
Craciun A; Lackner C; Cortez-Pinto H
Curr Pharm Des; 2020; 26(10):1093-1109. PubMed ID: 31969088
[TBL] [Abstract][Full Text] [Related]
15. Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors.
Takahashi Y; Dungubat E; Kusano H; Fukusato T
Biomedicines; 2023 Oct; 11(10):. PubMed ID: 37893134
[TBL] [Abstract][Full Text] [Related]
16. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
Wu J
Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
[TBL] [Abstract][Full Text] [Related]
17. NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk.
Ballestri S; Nascimbeni F; Baldelli E; Marrazzo A; Romagnoli D; Lonardo A
Adv Ther; 2017 Jun; 34(6):1291-1326. PubMed ID: 28526997
[TBL] [Abstract][Full Text] [Related]
18. Spectrum, Screening, and Diagnosis of Alcohol-related Liver Disease.
Hernandez-Tejero M; Clemente-Sanchez A; Bataller R
J Clin Exp Hepatol; 2023; 13(1):75-87. PubMed ID: 36647416
[TBL] [Abstract][Full Text] [Related]
19. Antioxidant Mechanisms in Nonalcoholic Fatty Liver Disease.
Liu W; Baker SS; Baker RD; Zhu L
Curr Drug Targets; 2015; 16(12):1301-14. PubMed ID: 25915484
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]